Honestly, my man. Don't waste your time. He has no idea what he is talking about. The only thing 'new' about this data is that it showcases all of the information that was withheld from investors for years.
The conference presentation is a selection of material from the original HER-Vaxx Gastric Cancer trial conducted in India and Eastern Europe that finished long ago. You'll find all of the information in the recent publication:
Phase II Trial of HER-Vaxx Paper.pdf
Check the introduction. It contains the clinicaltrials.gov number.
From the clinicaltrials.gov website. Clearly, nextHERIZON has a different NCT number.
IMU management would rather create a presentation to gather more investors than inform their current ones.
(20min delay)